Tofacitinib

XELJANZ

NADAC/unit $73.8329

No Shortage Tier 1: 83.6% PA Req: 387.2% 2 Manufacturers 2 ANDAs

XELJANZ (tablets and oral solution) and XELJANZ XR (extended-release tablets) are Janus kinase (JAK) inhibitors.

vs. brand XELJANZ: Generic saves up to -638% per unit

Covered Lives

Generic Manufacturers

BIOCON PHARMA LTDPF PRISM CVPFIZER INCSINOTHERAPEUTICS INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Tofacitinib drfinder.aiFind doctors who prescribe Tofacitinib rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Tofacitinib

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.